Metabolism
Metabolism(代谢)
- PPAR(219)
- 5-alpha Reductase(11)
- 5-Lipoxygenase(11)
- Adenosine Deaminase(10)
- Aminopeptidase(15)
- C14ɑ demethylase(2)
- Carbonic Anhydrase(55)
- CETP(9)
- Cholesterol absorption(1)
- CPT1(2)
- CYP3A/CYP450(22)
- Dehydrogenase(43)
- DHFR(7)
- DGAT(10)
- Dopamine β-hydroxylase(10)
- Enolase(5)
- FAAH(38)
- Factor Xa(61)
- Ferroptosis(198)
- Folate Analogue(2)
- Glucokinase(18)
- HLE(1)
- HMG-CoA Reductase(37)
- HSP(100)
- IDO(46)
- KRAS-PDEδ(3)
- MAO(6)
- Metabolic Enzymes(6)
- Neuronal Metabolism(8)
- Oxidative Phosphorylation(26)
- P450(456)
- PDE(250)
- Phospholipase(130)
- Procollagen C Proteinase(1)
- Saccharometabolism(1)
- SCD(20)
- SGLT(29)
- TPH(4)
- Transferase(26)
- Energy Metabolism
- Inorganic Ions
- ALP(1)
- Carbohydrates(36)
- Uric Acid
- Muscle Metabolism
- MDA
- MPO
- Transaminase(3)
- Glutathione Reductase(1)
- Thioredoxin Reductase
- Catalase(15)
- monooxygenase(1)
- PKM2(1)
- Aldehyde dehydrogenase(1)
- Squalene synthase(1)
- Hydrolase(17)
- ornithine decarboxylase(1)
- Amino acid metabolism(3)
- phosphatases(103)
- Pyruvate kinase(13)
- Others(64)
- MGL(1)
- Galactosidase(2)
- 12-Lipoxygenase(1)
- Fatty Acid Synthase (FASN)(9)
- Dihydroorotate Dehydrogenase(13)
- Bile Acids & Microbiome(131)
- Bone Growth & Remodeling(55)
- Carbohydrate Metabolism(166)
- Cofactors & Vitamins(87)
- Dyslipidemias(109)
- Inborn Errors of Metabolism(100)
- Metabolic Syndrome(22)
- Necroptosis(12)
- Necrosis(19)
- Nutrient Sensing(14)
- Phosphodiesterase(34)
- Reproductive Biology(184)
- Thermogenesis(10)
- Sterol Biosynthesis(42)
- Prolyl Hydroxylation Enzymes(2)
- Biliary System(16)
- Metabolic Disease(5)
- Fat Mass and Obesity-associated Protein (FTO)(5)
- SHIP(1)
- FOXO
- Furin(1)
- Liposome(8)
- MetAP
- PGC-1α
- PI5P4K(1)
- Metabolic Diseases(2)
Metabolism 相关产品(3072)
- GC35419AtorvastatinCAS: 134523-00-5纯度: >99.00% / >98.00% / >99.50%
阿托伐他汀(Atorvastatin)是一种口服活性HMG-CoA还原酶抑制剂,可以有效降低血脂
- GC35536BMS-962212CAS: 1430114-34-3
BMS-962212 是直接的,可逆的,选择性 FXIa 抑制剂。 BMS-962212 具有良好的耐受性,快速起效的药效 (PD) 反应和快速消除。 BMS-962212 在活化的部分促凝血酶原激酶时间内依赖性地增加暴露,并且在 FXI 凝血活性中依赖性地降低暴露。
- GC35565Bucladesine calcium saltCAS: 938448-87-4
Bucladesine 钙盐(Dibutyryl-cAMP 钙盐;DC2797 钙盐)是一种细胞可渗透的环 AMP (cAMP) 类似物,可通过增加细胞内 cAMP 水平选择性地激活 cAMP 依赖性蛋白激酶 (PKA)。
- GC35627CDC25B-IN-1CAS: 2374831-10-2纯度: >98.00%
CDC25B-IN-1 (compound 4a) 是一种有效的细胞分裂周期 25B (CDC25B) 磷酸酶抑制剂,其 Ki 值为 8.5 μM。CDC25B-IN-1 能有效抑制细胞增殖和克隆形成,导致 G2/M 期停滞。
- GC35788CYP17-IN-1CAS: 2093317-51-0
CYP17-IN-1 (compound 9c) 是一种有效的,具有口服活性的 CYP17 的抑制剂,对大鼠和人 CYP17 的 IC50 值为 15.8 和 20.1 nM。
- GC35791cyt-PTPε Inhibitor-1CAS: 428478-94-8
cyt-PTPε Inhibitor-1 是一种有效的胞质蛋白酪氨酸磷酸酶 cyt-PTPε 抑制剂,与 cyt-PTPε 的催化结构域结合,抑制 c-Src 的活化 (c-Src 去磷酸化),具有抗破骨细胞的活性。
- GC35803Dafadine-ACAS: 1065506-69-5纯度: >98.50%
Dafadine-A是dafadine类似物,是C. elegans DAF-9 细胞色素P450抑制剂,还能抑制哺乳动物的CYP27A1。
- GC35809Dapagliflozin ((2S)-1,2-propanediol, hydrate)CAS: 960404-48-2纯度: >99.50%
Dapagliflozin propanediol belongs to the class of orally administered antidiabetic agents designated as sodiumglucose cotransporter 2 (SGLT2) inhibitors.
- GC35837Deltasonamide 2 (TFA)CAS: 2235358-74-2纯度: >99.50%
Deltasonamide 2 TFA 是一种竞争性的,高亲和力的 PDEδ 抑制剂,Kd 值约为 385 pM。
- GC35838Deltasonamide 2 hydrochlorideCAS: 2448341-55-5纯度: >99.00%
Deltasonamide 2 hydrochloride 是一种竞争性的,高亲和力的 PDEδ 抑制剂,Kd 值为 ~385 pM.
- GC35876DL-GlutamineCAS: 6899-04-3纯度: >98.00%
DL-Glutamine (Glutamin, 2-amino-4-carbamoylbutanoic acid) is a non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes.
- GC35981EMT inhibitor-2CAS: 2232228-60-1
EMT inhibitor-2 (Compound 1) 抑制由免疫细胞释放的物质如 IL-1β 和 TGF-β 诱导的上皮-间质转化 (EMT)。EMT inhibitor-2 抑制CYP3A4 睾酮和 CYP2C9,IC50 分别为 49.72 和 5.54 μM。
- GC36004Ertugliflozin L-pyroglutamic acidCAS: 1210344-83-4纯度: >99.50%
Ertugliflozin (MK-8835, PF-04971729) L-pyroglutamic acid is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2) with IC50 of 0.877 nM for h-SGLT2. Ertugliflozin has the potential for the treatment of type 2 diabetes mellitus.
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC35399 | Artefenomel | 1029939-86-3 | >99.00% | |
An antimalarial agent | ||||
| GC35419 | Atorvastatin | 134523-00-5 | >99.00% / >98.00% / >99.50% | |
阿托伐他汀(Atorvastatin)是一种口服活性HMG-CoA还原酶抑制剂,可以有效降低血脂 | ||||
| GC35499 | Bestatin trifluoroacetate | 223763-80-2 | - | |
An aminopeptidase inhibitor | ||||
| GC35518 | Bilobetin | 521-32-4 | >98.00% | |
A biflavonoid with diverse biological activities | ||||
| GC35536 | BMS-962212 | 1430114-34-3 | - | |
BMS-962212 是直接的,可逆的,选择性 FXIa 抑制剂。 BMS-962212 具有良好的耐受性,快速起效的药效 (PD) 反应和快速消除。 BMS-962212 在活化的部分促凝血酶原激酶时间内依赖性地增加暴露,并且在 FXI 凝血活性中依赖性地降低暴露。 | ||||
| GC35543 | BPN14770 | 1606974-33-7 | >99.00% | |
Zatolmilast (BPN14770) is a selective allosteric inhibitor of phosphodiesterase 4D (PDE4D) with IC50 of 7.8 nM and 7.4 nM for PDE4D7 and PDE4D3, respectively. | ||||
| GC35565 | Bucladesine calcium salt | 938448-87-4 | - | |
Bucladesine 钙盐(Dibutyryl-cAMP 钙盐;DC2797 钙盐)是一种细胞可渗透的环 AMP (cAMP) 类似物,可通过增加细胞内 cAMP 水平选择性地激活 cAMP 依赖性蛋白激酶 (PKA)。 | ||||
| GC35603 | Canagliflozin hemihydrate | 928672-86-0 | >99.50% | |
An inhibitor of SGLT2 | ||||
| GC35627 | CDC25B-IN-1 | 2374831-10-2 | >98.00% | |
CDC25B-IN-1 (compound 4a) 是一种有效的细胞分裂周期 25B (CDC25B) 磷酸酶抑制剂,其 Ki 值为 8.5 μM。CDC25B-IN-1 能有效抑制细胞增殖和克隆形成,导致 G2/M 期停滞。 | ||||
| GC35657 | CETP-IN-3 | 939391-31-8 | - | |
CETP-IN-3 (Compound 13) 是血浆糖蛋白胆固醇酯转移蛋白 (CETP) 的小分子抑制剂,可抑制 CETP 活性并提高高密度脂蛋白胆固醇 (HDL-C) 水平。CETP-IN-3 抑制活力的IC50 值分别为0.002 μM (SPA), 0.06 μM (WPA) 。 | ||||
| GC35692 | Chrysosplenetin | 603-56-5 | >99.50% | |
A flavonoid with diverse biological activities | ||||
| GC35698 | Ciprofibrate D6 | 2070015-05-1 | - | |
An internal standard for the quantification of ciprofibrate | ||||
| GC35757 | Cucurbitacin D | 3877-86-9 | >98.00% | |
A triterpenoid with diverse biological activities | ||||
| GC35788 | CYP17-IN-1 | 2093317-51-0 | - | |
CYP17-IN-1 (compound 9c) 是一种有效的,具有口服活性的 CYP17 的抑制剂,对大鼠和人 CYP17 的 IC50 值为 15.8 和 20.1 nM。 | ||||
| GC35791 | cyt-PTPε Inhibitor-1 | 428478-94-8 | - | |
cyt-PTPε Inhibitor-1 是一种有效的胞质蛋白酪氨酸磷酸酶 cyt-PTPε 抑制剂,与 cyt-PTPε 的催化结构域结合,抑制 c-Src 的活化 (c-Src 去磷酸化),具有抗破骨细胞的活性。 | ||||
| GC35795 | D,L-Buthionine-(S,R)-sulfoximine hydrochloride | - | - | |
A γ-glutamylcysteine synthetase inhibitor | ||||
| GC35803 | Dafadine-A | 1065506-69-5 | >98.50% | |
Dafadine-A是dafadine类似物,是C. elegans DAF-9 细胞色素P450抑制剂,还能抑制哺乳动物的CYP27A1。 | ||||
| GC35809 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) | 960404-48-2 | >99.50% | |
Dapagliflozin propanediol belongs to the class of orally administered antidiabetic agents designated as sodiumglucose cotransporter 2 (SGLT2) inhibitors. | ||||
| GC35837 | Deltasonamide 2 (TFA) | 2235358-74-2 | >99.50% | |
Deltasonamide 2 TFA 是一种竞争性的,高亲和力的 PDEδ 抑制剂,Kd 值约为 385 pM。 | ||||
| GC35838 | Deltasonamide 2 hydrochloride | 2448341-55-5 | >99.00% | |
Deltasonamide 2 hydrochloride 是一种竞争性的,高亲和力的 PDEδ 抑制剂,Kd 值为 ~385 pM. | ||||
| GC35876 | DL-Glutamine | 6899-04-3 | >98.00% | |
DL-Glutamine (Glutamin, 2-amino-4-carbamoylbutanoic acid) is a non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. | ||||
| GC35962 | Edoxaban tosylate | 480449-71-6 | >99.00% | |
A potent inhibitor of Factor Xa | ||||
| GC35981 | EMT inhibitor-2 | 2232228-60-1 | - | |
EMT inhibitor-2 (Compound 1) 抑制由免疫细胞释放的物质如 IL-1β 和 TGF-β 诱导的上皮-间质转化 (EMT)。EMT inhibitor-2 抑制CYP3A4 睾酮和 CYP2C9,IC50 分别为 49.72 和 5.54 μM。 | ||||
| GC36004 | Ertugliflozin L-pyroglutamic acid | 1210344-83-4 | >99.50% | |
Ertugliflozin (MK-8835, PF-04971729) L-pyroglutamic acid is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2) with IC50 of 0.877 nM for h-SGLT2. Ertugliflozin has the potential for the treatment of type 2 diabetes mellitus. | ||||
